Viewing nowRimesin Tablet (Terbinafine Hydrochloride)
Terbinafine Hydrochloride 140.625mg
Tablet · Prescription medication
Daewoo Pharmaceutical Co., Ltd.

MFDS item code 200100713 · Notified 2001.11.06 · Insurance code 649600890
Treatment of onychomycosis and cutaneous fungal infections (e.g., tinea pedis and tinea corporis), and tinea capitis
This medication is used to treat fungal infections of the skin caused by dermatophytes, such as athlete's foot, tinea corporis, and tinea cruris in adults and tinea capitis in children. It is thus effective for various skin and nail fungal infections.
Administer 125 mg twice daily or 250 mg once daily. The duration of treatment according to the condition is as follows. 1) Dermatophytosis Tinea pedis (interdigital, plantar/moccasin type): 2~6 weeks Tinea corporis: 2∼4 weeks Tinea cruris: 2~4 weeks 2) Onychomycosis Treatment is generally administered for 6 weeks~3 months. In cases of infection of the fingernails or relatively small toenails, or in younger patients, the treatment period may be shortened to 3 months or less. A treatment period of 3 months is usually sufficient for toenail infections, but some patients may require 6 months or longer. The treatment period may be longer in patients with slow nail growth. For patients with creatinine clearance less than 50 mL per minute, reduce the daily dose by 1/2.
Administer to children aged 2 years and older. Administration is not recommended for children under 2 years of age because there is no experience with its use in this age group. Tinea capitis: 4 weeks Body weight less than 20 kg (under 5 years): Administer 62.5 mg once daily. Experience with use is limited; the decision to administer should be made after considering the benefits and risks of treatment. Body weight 20~40 kg (5~12 years): Administer 125 mg once daily. Body weight over 40 kg (over 12 years): Administer 250 mg once daily.
This medication is not recommended for patients with chronic liver disease or active liver disease. Liver function tests must be performed prior to administration and regularly monitored during treatment. If any symptoms of liver dysfunction occur, discontinue use immediately and consult a physician. This medication should not be used in patients with blood disorders or severe renal impairment, infants under 2 years of age, or nursing mothers. In particular, patients with genetic issues such as lactose intolerance should not receive this medication. Use with caution in elderly patients, patients with impaired kidney function, and children with low body weight. Discontinue use immediately if skin rashes or severe skin reactions occur. This medication may cause various side effects such as liver damage, blood disorders, skin reactions, gastrointestinal disturbances, and neurological symptoms, thus careful observation is required. Caution should be taken when driving or operating machinery if experiencing dizziness or other symptoms. Interactions with other medications may occur, so inform your doctor or pharmacist of any other medications you are taking. Women who are pregnant or may become pregnant should discuss with their physician before use, and nursing mothers should discontinue breastfeeding. This medication should be stored out of reach of children and kept at room temperature away from direct sunlight.
Continuous nausea, decreased appetite, fatigue, vomiting, upper right abdominal pain, jaundice, dark urine, loose stools, biliary tract failure, hepatitis, cholestasis, jaundice, rash, skin itching, fever, nausea, vomiting, anorexia, lethargy, elevated γ-GTP, elevated AST/ALT, elevated LDH, elevated ALP, neutropenia, pancytopenia, agranulocytosis, thrombocytopenia, pharyngitis, fever, lymphadenopathy, purpura, petechiae, leukopenia, anemia, rash, itching, photosensitive reaction, Stevens-Johnson syndrome, toxic epidermal necrolysis, acute generalized exanthematous pustulosis, erythema multiforme, toxic skin rash, exfoliative dermatitis, blistering dermatitis, psoriasiform rash, exacerbation of psoriasis, hair loss, musculoskeletal reactions, arthralgia, myalgia, weakness, elevated CPK, elevated serum myoglobin, elevated urinary myoglobin, hypotension, dyspnea, chest tightness, urticaria, erythema, facial edema, lymphangitis, abdominal distension, dyspepsia, mild abdominal pain, diarrhea, epigastric discomfort, thirst, glossitis, depression, anxiety, headache, loss of taste, taste disturbances, dizziness, drowsiness, paresthesia, sensory loss, decreased attention, insomnia, elevated BUN, frequent urination, visual impairment, tinnitus, anaphylactoid reaction, angioedema, systemic lupus erythematosus, elevated total cholesterol in the blood, elevated triglycerides, lethargy, tongue discoloration, palpitations, edema, menstrual irregularities, paralysis, systemic disorders, fever, fatigue, weight loss, anaphylactic reaction, serum sickness-like reaction, blurred vision, decreased vision, hearing impairment, auditory dysfunction, vasculitis, permanent anosmia, anosmia, hyposmia, eosinophilia, drug rash, pancreatitis, rhabdomyolysis, influenza-like illness, increased blood creatine phosphokinase, headache, nausea, upper abdominal pain, dizziness
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent air exposure, ideally at a temperature between 1 and 30 degrees Celsius. Doing so will help maintain the efficacy of the medication and ensure its safe use.
White round tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowTerbinafine Hydrochloride 140.625mg
Tablet · Prescription medication
Daewoo Pharmaceutical Co., Ltd.
Terbinafine Hydrochloride 10mg
Cream · OTC medication
GP Therapeutics Korea Co., Ltd.
Terbinafine Hydrochloride 10mg
Cream · OTC medication
Korea Hutex Pharmaceutical Co., Ltd.
Terbinafine Hydrochloride 10mg
Cream · OTC medication
Anguk Pharmaceutical Co., Ltd.
Terbinafine Hydrochloride 10mg
Cream · OTC medication
Medica Korea Co., Ltd.
Terbinafine Hydrochloride 10mg
Cream · OTC medication
Gyeongnam Pharmaceutical Co., Ltd.
Terbinafine Hydrochloride 10mg
Cream · OTC medication
Daehwa Pharmaceutical Co., Ltd.
Terbinafine Hydrochloride 10mg
Cream · OTC medication
Korea Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.